DIAsource ImmunoAssays

Name

DIAsource ImmunoAssays

Legal name

DIAsource ImmunoAssays S.A.

Website

https://diasource-diagnostics.com

Company type

Private

Founded year

1992

Operating status

Operating

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics (IVD)

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Clinical Chemistry & Immunoassay Systems (HLAHAAAA)

akta.pro secondary industries

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM), Immunoassay Diagnostics (ELISA, chemiluminescence, serology) (HLAAALAB), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

Keywords

• In vitro diagnostics
• Immunoassay kits
• Monoclonal antibodies
• Clinical diagnostics
• Laboratory automation

Headquarters

HQ city

Louvain-la-neuve

HQ country

Belgium

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. IVD Diagnostic Tests (RIA, ELISA, CLIA, BLOT): DIAsource generates revenue primarily from the sale of clinical in vitro diagnostic test kits based on Radioimmunoassay (RIA), ELISA, CLIA, and immunoblot technologies. Tests cover multiple disease fields including endocrinology, autoimmunity, infectious diseases, bone metabolism, cancer markers, fertility, diabetes, and more. Products are sold directly and through distributors globally.
2. Monoclonal Antibodies and Antigens: DIAsource develops and commercializes monoclonal antibodies and antigens. These are sold both for use in the company's own IVD kits and supplied as raw materials to other IVD manufacturers for their assay development needs. This represents both a product revenue stream and a B2B licensing/supply relationship with competitor IVD companies.
3. Laboratory Instruments: Sale of laboratory instruments including the Stratec Gemini automated ELISA processor, ELISA Plate Reader (DIA2000), ELISA Plate Washer (DIA3000), ELISA Plate Shaker (DIA4000), and Rapid Test Reader (DIA5000). Instruments are sold to clinical laboratories to automate DIAsource's and other immunoassay workflows.
4. S4FE-D CBRN Decontaminant Products: Sale of S4FE-D CBRN (Chemical, Biological, Radiological, Nuclear) decontamination products including concentrate, spray, and soap formulations. These are marketed to hospitals, nuclear pharmacies, and research labs for decontamination of radioactive particles and other contaminants.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

DIAsource ImmunoAssays develops, manufactures, and markets clinical in vitro diagnostic (IVD) test kits, laboratory instruments, and proprietary monoclonal antibodies and antigens. The portfolio is built on four core technology platforms — Radioimmunoassay (RIA), Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescent Immunoassay (CLIA), and immunoblot/DOT — covering endocrinology, autoimmunity, infectious diseases, bone metabolism, fertility, oncology, diabetes, and other disease fields for clinical laboratories and IVD manufacturers worldwide.

Product overview

DIAsource ImmunoAssays develops, manufactures, and markets clinical diagnostic products with over 30 years of experience. The portfolio consists of multiple complementary product lines: ImmunoAssays Tests (RIA and ELISA-based tests covering endocrinology, autoimmunity, infectious diseases, bone metabolism, cancer markers, and more); DIASPOT Technology for autoimmune diagnostics with DIASPOT Neptune automation; ELISA Instruments (DIA2000/3000/4000 trio and Stratec Gemini for automation); CE-IVD Rapid Tests with dedicated Reader (DIA5000); Antibodies & Antigens as raw materials; and CLIA Solutions. The offering spans from manual to fully automated systems, with technologies including RIA, ELISA, CLIA, DOT/immunodot, and rapid testing. S4FE-D CBRN Decontaminant products round out the portfolio for nuclear/radioactive contamination cleanup.

Differentiator

Problem solved

Functional benefit

Brands

• DIAsource Neptune: Automated instrument for autoimmunity tests using DIASPOT technology.
• DIASPOT Technology
• ELISA Trio
• DIA4000
• DIA3000
• DIA2000
• Rapid Test Reader (DIA5000)
• S4FE-D CBRN Decontaminant

Products and services

• ImmunoAssays Tests (RIA and ELISA) Wide range of clinical diagnostic tests based on Radioimmunoassay (RIA/IRMA) and Enzyme-Linked Immunosorbent Assay (ELISA) technologies detecting analytes in infectious diseases, endocrinology, autoimmunity, bone metabolism, fertility, oncology, diabetes, and other disease fields. Sold to clinical laboratories worldwide.
• Autoimmunity Tests (DIASPOT Technology) Autoimmune disease diagnostic tests using DIASPOT membrane technology (DOT) combining simplicity and reliability for identification of multiple autoantibodies in a single test. DIASPOT Multiquant enables up to 25 auto-antibodies detected and quantified per strip with full automation in 45 minutes.
• DIASPOT Neptune Automated Reader Automated instrument for fully automated processing of DIASPOT and DIASPOT Multiquant immunodot assays, with ready-to-use individual cartridges and Neptune Quantification Software for quantitative or semi-quantitative results reporting.
• ELISA Plate Reader (DIA2000) IVDR-compliant ELISA microplate reader with vertical 8-channel optical path for single and dual wavelength measurement, featuring 10.1-inch LCD touchscreen, LIS connectivity, and dedicated computer-side analysis software.
• ELISA Plate Washer (DIA3000) Microplate washer with two-point aspiration process producing residual volumes less than 1µL and customizable wash parameters for ELISA workflows.
• ELISA Plate Shaker (DIA4000) Plate shaker with direct brushless DC motor and PID intelligent temperature control for ELISA microplate incubation, with shaking range 200–1600 rpm and dual top/bottom heating.
• Stratec Gemini Fully Automated ELISA Processor Fully automated microplate processor for low-throughput ELISA applications featuring sample/reagent ID-barcode reading, in-tip dilution, intuitive open software, integrated PC and touchscreen, and capacity for up to 3 microplates simultaneously.
• CE-IVD Rapid Tests (POCT) CE-IVD-marked rapid immunochromatographic tests for Point-of-Care Testing covering the gastrointestinal panel (Adenovirus, Rotavirus, Norovirus, Calprotectin, Celiac, C. difficile, FOB, H. pylori, Salmonella), drug-of-abuse testing, women's health, tumor markers, infectious diseases, and cardiac markers.
• Rapid Test Reader (DIA5000) Dedicated reader instrument for automated/semi-automated interpretation of CE-IVD Rapid Tests, enabling quantitative results for point-of-care diagnostics.
• Monoclonal Antibodies and Antigens Monoclonal antibodies and antigens for diagnostic development including panels for gastrointestinal, bone metabolism, diabetes, thyroid function, fertility, and other diagnostic areas. Sold as raw materials to other IVD manufacturers for use in CLIA, ELISA, FIA, and POCT assays.
• CLIA (Chemiluminescent ImmunoAssay) Solution Chemiluminescent ImmunoAssay (CLIA) technology solutions for clinical diagnostics providing fully automated CLIA capabilities as part of the BioVendor Group joint product offering.
• S4FE-D CBRN Decontaminant Products CBRN decontamination products using proprietary Bind-It technology to eliminate chemical (98%), biological (98%), and radioactive (99%) contaminants, marketed to hospitals, nuclear pharmacies, and research labs in concentrate, spray, soap, and touchless wall dispenser formats.
• Bone Metabolism Immunoassay Tests Diagnostic tests for bone metabolism including Osteocalcin, parathyroid hormone (PTH) and Vitamin D detection, supporting evaluation of bone resorption and absorption processes for clinical laboratories.
• Cancer Markers Immunoassay Tests Serum tumor marker tests detecting molecules produced by tumors or by the body in response to the presence of cancer or certain benign conditions, used for cancer diagnosis and monitoring.
• Drug of Abuse Immunoassay Tests Rapid chromatographic immunoassay for detection of Cotinine (the nicotine metabolite) in human urine, sold for drug-of-abuse diagnostics.
• Thyroid Function Immunoassay Tests Complete thyroid panel for quantitative determination of T3, T4, Free T3, Free T4, TSH, Thyroglobulin, Anti-TPO, TgAb, TSH-R-Ab, and Reverse T3.
• Infectious Diseases Immunoassay Tests Diagnostic tests for infectious diseases including measles, syphilis, hepatitis, cytomegalovirus, malaria, varicella zoster, and other bacterial, viral, parasitic, and fungal infections.
• Fertility Immunoassay Tests Tests for fertility-related hormones including human follicle-stimulating hormone (hFSH), human luteinizing hormone (hLH), human chorionic gonadotropin (hCG), and androgens such as testosterone and DHEA.
• Diabetes & Metabolism Immunoassay Tests Diagnostic tests for diabetes and metabolic disorders including insulin and related biomarkers for Type 1, Type 2, and gestational diabetes monitoring.
• Gastrointestinal Immunoassay Tests Tests for gastrointestinal disorders including Pepsinogen I and II, Helicobacter pylori, Calprotectin, and Pancreatic polypeptide detection.
• Growth Factors Immunoassay Tests Tests for growth factors including IGF-1, IGFBP-1, IGFBP-2, IGFBP-3 and Somatomedin-C, used for growth assessment in pediatric examinations.
• Adrenal Function & Hypertension Immunoassay Tests Assays for quantitative determination of 11-DOC, ACTH, Cortisol, Aldosterone, Angiotensin I and II, CBG, Renin, PRA, and vasopressin (ADH) for evaluation of the Renin-Angiotensin System.
• Biogenic Amines & Neurosciences Immunoassay Tests Tests for biogenic amines including catecholamines (Epinephrine, Norepinephrine, Dopamine), Serotonin, and Histamine for neurotransmission and signaling functions.
• Hematology Markers Immunoassay Tests Tests for hematology markers providing a comprehensive view of patient blood composition and function.
• Hepatic Function Immunoassay Tests Diagnostic tests for hepatic function evaluation covering metabolism, digestion, detoxification, and elimination of substances from the body.
• Inflammation Markers Immunoassay Tests Tests for cytokine levels including Cyclosporine, Interferon Gamma, Interleukines (IL-1B, IL-6, IL-8, IL-10) and Tumor Necrosis Factor, used for understanding inflammation pathogenesis.
• Free Vitamin D Immunoassay Tests Specialized tests for free (unbound) vitamin D detection in clinical diagnostics.
• Radioimmunoassay (RIA/IRMA) Test Kits RIA and IRMA (Immunoradiometric assay) kits using Iodine-125 (I-125) radioisotope for highly sensitive and specific measurement of picomolar concentrations of hormones, drugs, antibodies, and proteins.

Quantifiable outcome

• Picometer concentration sensitivity achievable with RIA technology
• +3 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature7 records

Partnerships

One partnership is on record.

• BioVendor GroupcoreStrategic or Co-development PartnerDIAsource is a brand within the BioVendor Group, an international group of biotechnology companies with its own research, development, production of IVD products and distribution network. BioVendor Group brands include BioVendor LM, BioVendor R&D, TestLine, DiaSource, ViennaLab, and BioVendor MDx. DIAsource shares exhibition booths and joint marketing at major trade shows with other Group companies.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• bioMérieux: French in vitro diagnostics company with strong positions in immunoassay, microbiology, and infectious disease testing. Overlaps with DIAsource in clinical immunoassay markets globally.
• Tecan: Swiss lab automation and diagnostics instrumentation company. Comparable through overlapping ELISA processing instruments (such as the Stratec Gemini DIAsource distributes) and broader IVD workflow automation.
• Roche Diagnostics: Global IVD market leader with broad immunoassay (Elecsys/Cobas), clinical chemistry, and infectious disease testing platforms. Overlaps with DIAsource across all major disease fields but operates at vastly larger scale.
• Abbott Diagnostics: Major IVD incumbent with Architect/Alinity immunoassay systems covering endocrinology, infectious disease, and oncology. Direct competitor across DIAsource's core testing categories with much larger installed base.

Direct peers

• Monobind: US-based IVD company specializing in ELISA and CLIA immunoassays for endocrinology, infectious disease, and autoimmune diagnostics. Closely comparable mid-sized niche player targeting similar clinical laboratory customers.
• DiaSorin: Italian IVD specialist with deep focus on immunodiagnostics and CLIA technology, serving endocrinology, infectious disease, and autoimmune testing. Direct competitor to DIAsource across immunoassay disease fields and laboratory automation.
• BioVendor R&D: Direct sister subsidiary within BioVendor Group, also focused on IVD and immunoassay development. Operates in the same corporate ecosystem with overlapping antibody/antigen portfolios and shared distribution infrastructure, making it the closest structural peer.
• TestLine Clinical Diagnostics: Czech IVD manufacturer specializing in ELISA kits for infectious disease and autoimmune diagnostics; also a sister brand within BioVendor Group. Highly comparable in technology platform, disease field focus, and customer base.
• IBL International: German specialty immunoassay manufacturer with ELISA and RIA expertise serving endocrinology and neurology research/clinical diagnostics. Directly comparable in technology platforms and niche IVD focus.

Emerging players

• Snibe Diagnostic: Chinese IVD company specializing in chemiluminescence immunoassay (CLIA) systems. Comparable to DIAsource's CLIA initiative and a fast-growing emerging competitor, particularly in Asia-Pacific markets where DIAsource has trade-show presence.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/biovendor-group

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DIAsource ImmunoAssays